IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8957065 B1

PDFFull Text
Date of Patent:
Feb. 17, 2015

Filed:

Jun. 20, 2011

Fused pyrimidine derivatives for inhibition of tyrosine kinase activity

Applicants:

MI Young Cha, Seongnam-si, KR;

Seok Jong Kang, Okcheon-gun, KR;

MI Ra Kim, Seoul, KR;

Ju Yeon Lee, Gwangju, KR;

Ji Young Jeon, Gunpo-si, KR;

Myoung Gi JO, Anyang-si, KR;

Eun Joo Kwak, Seogwipo-si, KR;

Kwang OK Lee, Yongin-si, KR;

Tae Hee Ha, Hwaseong-si, KR;

Kwee Hyun Suh, Suwon-si, KR;

Maeng Sup Kim, Seoul, KR;

Inventors:

Mi Young Cha, Seongnam-si, KR;

Seok Jong Kang, Okcheon-gun, KR;

Mi Ra Kim, Seoul, KR;

Ju Yeon Lee, Gwangju, KR;

Ji Young Jeon, Gunpo-si, KR;

Myoung Gi Jo, Anyang-si, KR;

Eun Joo Kwak, Seogwipo-si, KR;

Kwang Ok Lee, Yongin-si, KR;

Tae Hee Ha, Hwaseong-si, KR;

Kwee Hyun Suh, Suwon-si, KR;

Maeng Sup Kim, Seoul, KR;

Assignee:

Hanmi Science Co., Ltd, Hwaseong-si, KR;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Susanna Moore

Int. Cl.
CPC ...
C07D 495/04 (2006.01); A61K 31/519 (2006.01); A61K 31/55 (2006.01); A61K 31/5355 (2006.01); A61P 35/00 (2006.01); A61P 29/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 19/02 (2006.01); A61P 17/06 (2006.01); A61P 11/06 (2006.01); A61P 9/00 (2006.01); A61P 3/10 (2006.01); A61P 13/12 (2006.01); A61P 7/10 (2006.01); A61P 25/28 (2006.01); A61P 25/16 (2006.01); A61P 25/02 (2006.01); C07D 519/00 (2006.01); A61K 31/675 (2006.01); C07D 491/048 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/553 (2006.01); C07F 9/6561 (2006.01); C07D 491/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); C07F 9/6561 (2013.01);
Abstract

The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Find Patent Forward Citations

Loading…